|1.||Castanho, Miguel A R B: 3 articles (07/2013 - 07/2006)|
|2.||Tavares, Isaura: 2 articles (07/2013 - 01/2013)|
|3.||Bardaji, Eduard: 1 article (07/2013)|
|4.||Santos, Sara M: 1 article (07/2013)|
|5.||Sousa, David S C: 1 article (07/2013)|
|6.||Santos, Sónia Sá: 1 article (07/2013)|
|7.||Ribeiro, Marta M B: 1 article (07/2013)|
|8.||Oliveira, Margarida: 1 article (07/2013)|
|9.||Heras, Montserrat: 1 article (07/2013)|
|10.||Santos, Sara Matos: 1 article (01/2013)|
05/01/2000 - "An enzymatically stable kyotorphin analog induces pain in subattomol doses."
11/01/1991 - "Above results suggest that kyotorphin acts as a putative neuromediator and/or an endogenous pain modulator in the human brain."
11/01/1991 - "[Kyotorphin like substance in human cerebrospinal fluid of patients with persistent pain]."
10/06/1980 - "Kyotorphin may play a physiological role in pain control in the central nervous system."
03/01/2003 - "The spinal analgesic effects of Kyotorphin (Kyo) and Melanocyte-inhibiting factor (MIF-l) were studied during acute pain in rats chronically implanted with intrathecal (i.t.) cannulas. "
01/01/2004 - "Effects of kyotorphin and analogues on nociception and pentylenetetrazole seizures."
01/01/1995 - "Seizure-protecting effects of kyotorphin and related peptides in an animal model of epilepsy."
01/01/1998 - "[Effect of kyotorphin on the seizure activity induced by kainic acid during picrotoxin kindling in rats]."
01/01/1995 - "Administration of peptides kyotorphin (KT), neokyotorphin (NKT), and d-ser-2-NKT into the lateral brain ventricle (10 nmol) increased the latency and attenuated the severity of picrotoxin-induced convulsions in rats. "
11/05/1982 - "The primary structure of the tumor-derived peptide is H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala- Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly -Ala-Arg-Ala-Arg-Leu-NH2. "
07/01/1984 - "Amino acid sequence determination using a gas-phase sequencer and reverse-phase liquid chromatography of the native peptide and its synthetic replicates showed its primary structure to be as follows: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln -Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser -Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2, which is identical to that of the GRF recently isolated and characterized from a human pancreatic tumor that had caused acromegaly. "
|4.||Ganglion Cysts (Ganglion)
|2.||Opioid Analgesics (Opioids)